GRACE Targeted Therapies Lung Cancer 2021 - ROS1 & ALK Treatments Transform Neuroendocrine Tumor

GRACE Targeted Therapies Lung Cancer 2021 - ROS1 & ALK Tr...

Cancer Photo
2 weeks
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time.

For the full agenda, visit , and for information on the faculty,

In this video, from the ALK/ROS1 breakout session, Drs. Jessica Lin and Chul Kim discuss what treatment options are available for ROS1 and ALK cancer that transforms to a neuroendocrine tumor.

A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech

For more, please visit To join the conversation, visit